Stay updated on ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The new screenshots show minor UI updates to the page header and layout without changes to trial details, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:21:04.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    5%
    Check dated 2025-10-05T10:20:48.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Updated contact details and page revision from v3.0.2 to v3.1.0; added new phone numbers and email, with the old revision note removed.
    Difference
    0.1%
    Check dated 2025-09-28T03:19:30.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing the previous v3.0.1. Additionally, the Back to Top link has been removed, indicating a minor navigation cleanup.
    Difference
    0.3%
    Check dated 2025-09-13T17:41:39.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-06T15:26:42.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while removing specific location details and previous drug information. The revision number has also been updated from v2.16.12 to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T12:09:46.000Z thumbnail image

Stay in the know with updates to ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABX196+Nivolumab in Hepatocellular Carcinoma Clinical Trial page.